Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 3
2002 4
2003 2
2004 10
2005 8
2006 17
2007 4
2008 6
2009 4
2010 2
2011 5
2012 7
2013 8
2014 3
2015 6
2016 3
2017 2
2018 6
2019 4
2020 1
2021 2
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 24043661

105 results
Results by year
Filters applied: . Clear all
Page 1
The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.
Bond M, Rogers G, Peters J, Anderson R, Hoyle M, Miners A, Moxham T, Davis S, Thokala P, Wailoo A, Jeffreys M, Hyde C. Bond M, et al. Health Technol Assess. 2012;16(21):1-470. doi: 10.3310/hta16210. Health Technol Assess. 2012. PMID: 22541366 Free PMC article. Review.
Donepezil for dementia due to Alzheimer's disease.
Birks JS, Harvey RJ. Birks JS, et al. Cochrane Database Syst Rev. 2018 Jun 18;6(6):CD001190. doi: 10.1002/14651858.CD001190.pub3. Cochrane Database Syst Rev. 2018. PMID: 29923184 Free PMC article. Review.
105 results